Aurobindo Pharma Limited
NSE: AUROPHARMA · Healthcare
₹1,617.80
+9.80 (+0.61%)
Last close · 30 Aug 2026, 10:47 am IST
- Open
- ₹1,604.10
- Day high
- ₹1,623.80
- Day low
- ₹1,598.80
- Volume
- 5.90 L
- Prev close
- ₹1,608.00
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 200Nifty 500Nifty HealthcareNifty Midcap 100Nifty Midcap 150Nifty Midcap 50Nifty Midcap SelectNifty MidSmallcap 400Nifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 88,148 Cr
- Price
- 1,532.00
- P/E (TTM)
- 25.38
- P/E (Fwd)
- 16.95
- P/B
- 2.35
- EV/EBITDA
- 12.61
- EV/Revenue
- 2.57
- PEG
- —
- Div Yield
- 0.26%
- 52W High
- 1,636.80
- 52W Low
- 1,016.10
- Beta
- 0.02
Profitability & income
- Revenue (TTM)
- 33,653 Cr
- Net Income (TTM)
- 3,505 Cr
- EBITDA
- 6,856 Cr
- Gross Margin
- 59.92%
- Op. Margin
- 14.94%
- Net Margin
- 10.41%
- ROE
- 9.93%
- ROA
- 5.86%
- EPS (TTM)
- 60.36
- EPS (Fwd)
- 90.36
Financial health
- Total Debt
- 8,073 Cr
- Total Cash
- 10,618 Cr
- Debt/Equity
- 21.31
- Current Ratio
- 1.81
- Quick Ratio
- 0.98
- Book Value
- 652.31
- Free Cash Flow
- 1,319 Cr
- Op. Cash Flow
- 5,526 Cr
Growth
- Revenue Growth
- 5.60%
- Earnings Growth
- 1.90%
- Earnings QoQ
- 2.00%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 8,752 Cr | 921 Cr | 1,867 Cr | 1,322 Cr | 5,322 Cr | — | 8,073 Cr | 37,891 Cr |
| 2025-12-31 | 8,605 Cr | 910 Cr | 1,896 Cr | 1,309 Cr | 5,123 Cr | — | — | — |
| 2025-06-30 | 7,792 Cr | 825 Cr | 1,710 Cr | 1,198 Cr | 4,553 Cr | — | — | — |
| 2025-03-31 | 8,381 Cr | 903 Cr | 1,895 Cr | 1,347 Cr | 4,953 Cr | — | 8,263 Cr | 32,653 Cr |
| 2024-12-31 | 7,893 Cr | 846 Cr | 1,737 Cr | 1,209 Cr | 4,578 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 33,385 Cr | 3,505 Cr | 7,274 Cr | 5,078 Cr | 19,896 Cr | 5,526 Cr | 8,073 Cr | 37,891 Cr |
| 2025-03-31 | 31,378 Cr | 3,486 Cr | 7,173 Cr | 4,956 Cr | 18,352 Cr | 3,925 Cr | 8,263 Cr | 32,653 Cr |
| 2024-03-31 | 28,705 Cr | 3,173 Cr | 6,140 Cr | 4,442 Cr | 15,468 Cr | 2,435 Cr | 6,648 Cr | 29,843 Cr |
| 2023-03-31 | 24,617 Cr | 1,928 Cr | 3,986 Cr | 2,538 Cr | 12,717 Cr | 2,387 Cr | 5,286 Cr | 26,840 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for AUROPHARMA?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in